TickerFactsScreenerDevelopers

Xilio Therapeutics, Inc. (XLO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$54.56M2021: -$75.04M2022: -$89.15M2023: -$79.13M2024: -$60.58M2025: -$41.98M-$41.98M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$41.98M+30.7%
2024-$60.58M+23.4%
2023-$79.13M+11.2%
2022-$89.15M-18.8%
2021-$75.04M-37.5%
2020-$54.56M—